These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37675262)

  • 1. Age-related outcomes in patients with cardiogenic shock stratified by etiology.
    Schmitt A; Weidner K; Rusnak J; Ruka M; Egner-Walter S; Mashayekhi K; Tajti P; Ayoub M; Akin I; Behnes M; Schupp T
    J Geriatr Cardiol; 2023 Aug; 20(8):555-566. PubMed ID: 37675262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tricuspid regurgitation on the prognosis of patients with cardiogenic shock.
    Ruka M; Schupp T; Weidner K; Egner-Walter S; Forner J; Mashayekhi K; Tajti P; Ayoub M; Akin M; Behnes M; Akin I; Rusnak J
    Curr Med Res Opin; 2024 Jul; 40(7):1083-1092. PubMed ID: 38720658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of body mass index with 30-day all-cause mortality in cardiogenic shock.
    Schmitt A; Schupp T; Rusnak J; Weidner K; Ruka M; Egner-Walter S; Mashayekhi K; Tajti P; Ayoub M; Behnes M; Akin I
    Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):426-435. PubMed ID: 38000994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry.
    Schupp T; Rusnak J; Egner-Walter S; Ruka M; Dudda J; Bertsch T; Müller J; Mashayekhi K; Tajti P; Ayoub M; Akin I; Behnes M
    Clin Res Cardiol; 2024 Apr; 113(4):626-641. PubMed ID: 37093246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?
    Schmitt A; Schupp T; Rusnak J; Ruka M; Egner-Walter S; Mashayekhi K; Tajti P; Ayoub M; Behnes M; Akin I; Weidner K
    Int J Cardiol; 2023 Jun; 381():105-111. PubMed ID: 37004944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Dimer Levels and the Risk of 30-Day All-Cause Mortality in Cardiogenic Shock Stratified by Etiology.
    Schupp T; Behnes M; Rusnak J; Ruka M; Dudda J; Forner J; Schmitt A; Egner-Walter S; Bertsch T; Kittel M; Akin I
    Clin Lab; 2023 Oct; 69(10):. PubMed ID: 37844039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?
    Schupp T; Behnes M; Rusnak J; Ruka M; Dudda J; Forner J; Egner-Walter S; Barre M; Abumayyaleh M; Bertsch T; Müller J; Akin I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock.
    Schupp T; Rusnak J; Forner J; Weidner K; Ruka M; Egner-Walter S; Dudda J; Bertsch T; Kittel M; Behnes M; Akin I
    J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Prognostic Impact of Early Acute Kidney Injury in Cardiogenic Shock: Results from a Monocentric, Prospective Registry.
    Schupp T; Behnes M; Rusnak J; Weidner K; Ruka M; Dudda J; Schmitt A; Forner J; Egner-Walter S; Ayasse N; Bertsch T; Kittel M; Akin I
    Cardiorenal Med; 2024; 14(1):81-93. PubMed ID: 38316116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Outcome of Patients with Cardiogenic Shock Associated with In-Hospital or Out-of-Hospital Cardiac Arrest.
    Rusnak J; Schupp T; Weidner K; Ruka M; Egner-Walter S; Forner J; Bertsch T; Kittel M; Mashayekhi K; Tajti P; Ayoub M; Behnes M; Akin I
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic Shock.
    Behnes M; Rusnak J; Egner-Walter S; Ruka M; Dudda J; Schmitt A; Forner J; Mashayekhi K; Tajti P; Ayoub M; Weiß C; Akin I; Schupp T
    Chest; 2024 Jan; 165(1):110-127. PubMed ID: 37579943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the AST/ALT Ratio versus Bilirubin in Patients with Cardiogenic Shock.
    Schupp T; Rusnak J; Weidner K; Ruka M; Egner-Walter S; Dudda J; Forner J; Bertsch T; Mashayekhi K; Ayoub M; Akin M; Kittel M; Behnes M; Akin I
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Advanced Lung Cancer Inflammation Index Ratio in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Cohort Study.
    Gong M; Sasmita BR; Zhu Y; Chen S; Wang Y; Xiang Z; Jiang Y; Luo S; Huang B
    Rev Cardiovasc Med; 2024 Jul; 25(7):267. PubMed ID: 39139443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Lactate on 30-Day All-Cause Mortality in Patients with and without Out-of-Hospital Cardiac Arrest Due to Cardiogenic Shock.
    Rusnak J; Schupp T; Weidner K; Ruka M; Egner-Walter S; Forner J; Bertsch T; Kittel M; Mashayekhi K; Tajti P; Ayoub M; Behnes M; Akin I
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36555911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of admission D-dimer level in patients with cardiogenic shock after acute myocardial infarction.
    Jiang Y; Zhu Y; Xiang Z; Sasmita BR; Wang Y; Ming G; Chen S; Luo S; Huang B
    Front Cardiovasc Med; 2022; 9():1083881. PubMed ID: 36698952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cardiovascular Risk Factors on 30-Day All-Cause Mortality in Cardiogenic Shock.
    Forner J; Schupp T; Weidner K; Ruka M; Egner-Walter S; Behnes M; Akin M; Ayoub M; Mashayekhi K; Akin I; Rusnak J
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study.
    Sasmita BR; Zhu Y; Gan H; Hu X; Xue Y; Xiang Z; Liu G; Luo S; Huang B
    Shock; 2022 Mar; 57(3):351-359. PubMed ID: 34710884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shock.
    Schupp T; Behnes M; Rusnak J; Dudda J; Forner J; Ruka M; Egner-Walter S; Bertsch T; Müller J; Akin I
    Coron Artery Dis; 2023 Sep; 34(6):395-403. PubMed ID: 37139569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI.
    Chien SC; Wang CA; Liu HY; Lin CF; Huang CY; Chien LN
    Ann Intensive Care; 2024 May; 14(1):74. PubMed ID: 38735891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Hemoglobin Levels in Patients with Cardiogenic Shock of Any Cause: Insights from a Single-Centre, Prospective Registry.
    Dudda J; Weidner K; Behnes M; Rusnak J; Ruka M; Egner-Walter S; Forner J; Bertsch T; Akin I; Schupp T
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.